Home » Stocks » CSII

Cardiovascular Systems, Inc. (CSII)

Stock Price: $34.90 USD 0.41 (1.19%)
Updated November 23, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 1.40B
Revenue (ttm) 232.60M
Net Income (ttm) -23.53M
Shares Out 40.12M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $34.90
Previous Close $34.49
Change ($) 0.41
Change (%) 1.19%
Day's Open 34.47
Day's Range 34.34 - 34.97
Day's Volume 333,159
52-Week Range 26.00 - 55.22

More Stats

Market Cap 1.40B
Enterprise Value 1.20B
Earnings Date (est) Feb 3, 2021
Ex-Dividend Date n/a
Shares Outstanding 40.12M
Float 38.91M
EPS (basic) -0.67
EPS (diluted) -0.66
FCF / Share -0.34
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 982,230
Short Ratio 3.91
Short % of Float 2.52%
Beta 1.30
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.02
PB Ratio 5.43
Revenue 232.60M
Operating Income -22.50M
Net Income -23.53M
Free Cash Flow -13.17M
Net Cash 202.17M
Net Cash / Share 5.04
Gross Margin 80.73%
Operating Margin -9.67%
Profit Margin -10.10%
FCF Margin -5.66%
ROA -4.09%
ROE -11.47%
ROIC -16.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (10)

Buy 5
Overweight 1
Hold 3
Underweight 1
Sell 0

Analyst Consensus: Overweight

Price Target

$44.25*
(26.79% upside)
Low
38.0
Current: $34.90
High
50.0
Target: 44.25
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue23724821720517818213710482.4978.78
Revenue Growth-4.63%14.27%5.92%15%-1.85%32.89%31.49%25.95%4.71%-
Gross Profit18820017816514314210679.5263.2762.50
Operating Income-26.77-0.832.23-1.54-56.08-32.64-33.49-22.42-14.47-8.81
Net Income-27.24-0.261.71-1.79-56.02-32.82-35.29-24.04-16.79-11.13
Shares Outstanding34.2833.5433.1532.3732.5431.5528.3021.6918.0415.92
Earnings Per Share-0.79-0.010.05-0.06-1.72-1.04-1.25-1.11-0.93-0.70
Operating Cash Flow-12.7710.219.6719.59-23.58-22.36-26.84-10.77-11.34-8.36
Capital Expenditures-3.37-2.67-1.96-0.98-3.82-20.33-12.72-1.67-0.44-1.08
Free Cash Flow-16.137.547.7218.61-27.40-42.68-39.56-12.44-11.78-9.44
Cash & Equivalents23212311710961.3285.7212767.9035.5321.16
Total Debt20.8220.9721.0621.10--2.4012.5717.5212.14
Net Cash / Debt21110295.7487.5261.3285.7212455.3318.019.02
Assets34021920319414217118296.9063.1246.76
Liabilities70.7370.6368.8875.5541.5131.8929.8530.0730.9425.12
Book Value26914813411810113915266.8332.1921.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cardiovascular Systems, Inc.
Country United States
Employees 779
CEO Scott R. Ward

Stock Information

Ticker Symbol CSII
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: CSII
IPO Date February 26, 2009

Description

Cardiovascular Systems, a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.